7th Cell and Gene Therapy Summit Live Online 2022
12 November 2013 - 14 November 2013
Manila, Phillippines

Our Speakers

  • Han Jeong HoonHan Jeong Hoon
    Chief Business Officer
    Eutilex
  • Roberto NitschRoberto Nitsch
    Associate Director
    AstraZeneca
  • Dr Prateek GuptaDr Prateek Gupta
    Vice President and Head, Process Development & MSAT
    Stelis Biopharma Ltd
  • Dr Markus HaindlDr Markus Haindl
    Global Head of Gene Therapy Development
    Roche
  • Dr Gail NaughtonDr Gail Naughton
    Chief Scientific Officer & Founder
    Histogen
  • Dr Sandy QlintangDr Sandy Qlintang
    Deputy Director
    Stem Cell and Cancer Institute KALBE
  • Dr Seong-Wook LeeDr Seong-Wook Lee
    President and CEO
    Rznomics Inc.
  • Dr Jenny PrangeDr Jenny Prange
    Chief Scientific Officer
    MUVON Therapeutics
  • Dr Angeliki GrammenosDr Angeliki Grammenos
    Global Regulatory Affairs Associate Project Lead
    Debiopharm
  • Dr Akhilesh SharmaDr Akhilesh Sharma
    President and Chief Medical Officer
    Alkem Laboratories Ltd.
  • Magali TAIELMagali TAIEL
    Chief Medical Officer
    GenSight Biologics
  • Dr. Hemant DhamneDr. Hemant Dhamne
    Head of Gene & Cell Therapy Research
    Immnueel Therapeutics
  • Dr Shashwati BasakDr Shashwati Basak
    Associate Vice President Associate Vice President, Head, Cell Therapies and Analytical
    Center of Cell and Gene Therapy, Intas Pharmaceuticals Ltd. (Biopharma Division)
  • Dr Sareina WuDr Sareina Wu
    Founder and Chief Scientific Officer,
    GenomeFrontier Therapeutics
View All Speakers

Highly Rated Cell & Gene Therapy Summit Returns LIVE ONLINE!

Continuing advances in cell and gene therapy (CGT) are transforming how we treat and potentially cure certain diseases.  More than 750 trials of CGTs in almost 30,000 patients were underway as of June 2020, and CGT products account for some 12 percent of the pharmaceutical industry’s clinical pipeline and at least 16 percent of its preclinical pipeline.  All of these activities reflect the hope that CGTs will expand the still-limited treatment options available to many patients and transform the clinical paradigm.

Significant investment is going into this sector. Looking to the future, biopharmaceutical , biotech companies, and other stakeholders, including regulators and researchers will need to collaborate to develop a new pipeline of research from biological concept to medical practice. There are however several challenges which needs to be overcome and debated including manufacturing processes, scalability, regulatory compliance, pharmacovigilance & risk management, post-marketing activities, commercialization & market access, and patient evaluation & side-effect management amongst others.

This is why you must attend the 7th Cell & Gene Therapy Summit 2022 where global expert speakers will discuss the most important topics on emerging advances in the field of cell and gene therapy, the regenerative potential of stem cells, application of T- cells and Cart-T in the field of immuno-oncology, novel gene-editing tools and delivery methods, vector development, regulatory approaches, commercialisation strategies, ethical considerations and more in order to help you improve efficiencies across all phases of Cell & Gene Therapy development & production  

10 Key Reasons to Attend this ONLY 3 Day Conference Globally!

  • Learn and benchmark yourself with leading cell & gene therapy experts so that your manufacturing & process development is effective and generates ROI
  • Gain insights into how you can transit to a standardized process and ensuring GMP when it comes to raw material selection, supply, manufacturing and quality assurance of cell & gene therapy development
  • Managing Regulatory Compliance and approvals pertaining to cell & gene therapy development
  • Develop best practices pertaining to product development. product characterization and scalability for cell & gene therapy developments
  • Evaluate Pharmacovigilance, Safety & Risk Management Strategies for Cell & Gene Therapy Development
  • Explore the latest gene editing and delivery tools and technologies
  • Find out how you can develop effective commercialization and market access strategies for your Cell & Gene Therapy Development
  • Overcoming challenges pertaining to Gene Edited Ex Vivo Cell Therapies, and in Vivo Gene Therapies development
  • Gain insight into the most recent methodologies for faster, smaller, smarter clinical trials robust enough for marketing application of your treatments
  • Develop effective post-marketing activities, patient selection and evaluation strategies for cell & gene therapy products

Who Should Attend?

This event is tailor-made for Heads, Program Leads, Senior Managers & Executives from across pharmaceutical, biopharmaceutical and biotechnology companies involved in cell & gene therapy developments including the following departments:

  • R&D
  • Scientific Affairs
  • Medical Affairs
  • Manufacturing
  • Process Development
  • Portfolio Management
  • Regulatory Affairs
  • Quality Assurance
  • Commercial
  • Patient Advocacy
  • Pricing & Market Access

Like More Information?

What are you waiting for? Reserve your seat today and take advantage of the early bird discounted prices! Don’t miss your chance to be involved in the 7th Cell & Gene Therapy Summit 2022, Live Online, and be updated with the latest market information you will need to stay on top of the game!

Email us today at enquiry@equip-global.com!

Register Now
Register By 31 March 2022 to Enjoy Early Bird Discounted Rates!

Knowledge Center

Visit the Download Centre to access related reports, articles, interviews and other useful resources

Quick Links

PIC – 40% cash back when you register for an Equip Global Conference or Training Course

The objectives of the PIC Scheme are the same as those of Equip Global. Both support investment in innovation, productivity and continuous training.

If you are a registered business in Singapore, you can enjoy huge huge tax savings in the form of cash payouts and/or tax deductions when you invest in training of employees. Your attendance at any Equip Global conference or training course is eligible for PIC credits, either as a 40% cash refund or 400% tax deduction. We will provide you with full supporting documentation after the event and assist you in getting the claim completed.

Continuous training and upgrading of your employees is key to the success of your organization. What’s more, boost your tax savings and claim 40% of your registration fee by attending an Equip Global conference or training course today. To do so, follow this simple 5 minute process:

  1. Select, register and pay for your conference/training course of your choice
  2. Complete the PIC form which you can download here: http://www.iras.gov.sg/irasHome/uploadedFiles/Quick_Links/Tax_forms/Business_and_employers/Cash%20Payout%20Application%20Form_B2011_final.xls
  3. Attend the event, learn and network with industry peers
  4. File your receipt (which we will email you), record of attendance (which we will provide you at the event) and the completed PIC form with your accounts department which they will submit to IRAS to process the claim. If you do not have an accounts department or need help with the PIC claim, our staff will be very happy to assist.

Take advantage of the PIC scheme to upgrade your skills, gain the latest information in your field of work, and get access to the knowledge that can help drive your organizations’ performance and productivity.

For more information visit http://www.iras.gov.sg/irashome/picredit.aspx. Terms and conditions apply.

Tell a Colleague

7th Cell and Gene Therapy Summit Live Online 2022
19 July 2022 - 21 July 2022
Singapore
  • Thank you. We have sent an email with the event details to your colleague.
    [ Close Popup]
Copyright EquipGlobal 2017 All Rights Reserved